Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Acad Dermatol ; 72(1): 85-91, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25440959

ABSTRACT

BACKGROUND: Myotonic dystrophy type 1 (MD1) is reported to be associated with internal malignancies. The association of myotonic dystrophy with cutaneous tumors is not fully understood. OBJECTIVE: We sought to explore the total nevi count and the presence of atypical nevi, cutaneous melanoma, and other skin neoplasms in a representative cohort of patients with MD1 and to compare the findings with age- and sex-matched control subjects. METHODS: In all, 90 patients with MD1 and 103 age- and sex-matched control subjects were assessed for cutaneous neoplasms by clinical skin and epiluminescence examination (dermoscopy). Where indicated, subsequent excisions were performed. In patients with MD1, leukocyte n(CTG) expansion was measured. RESULTS: Patients with MD1 showed significantly higher numbers of nevi, dysplastic nevi, and melanomas despite a significantly greater proportion of the control subjects reporting sunburns. In addition, we found a significantly greater number of pilomatrixoma in patients with MD1. LIMITATIONS: Our study is limited by the fact that there is no agreed-upon standardized technique to assess for prior sun exposure. Further research in the association of cutaneous neoplasms and MD1 including vitamin D and molecular biological techniques are also recommended. CONCLUSION: MD1 itself may predispose to development of skin tumors.


Subject(s)
Dysplastic Nevus Syndrome/complications , Dysplastic Nevus Syndrome/epidemiology , Melanoma/complications , Melanoma/epidemiology , Myotonic Dystrophy/complications , Skin Neoplasms/complications , Skin Neoplasms/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Prevalence , Young Adult
2.
Dermatol Surg ; 39(7): 974-80, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23437916

ABSTRACT

BACKGROUND: Epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by immunologic abnormalities, disseminated human papilloma virus infection, and early development of skin cancers. Acquired forms have been rarely reported and usually occur with immunosuppression. The therapeutic management of the acquired forms is not standardized, and several therapies have been tried, with variable outcomes. OBJECTIVES: To provide updated clinical and experimental information on the treatment of acquired EV. METHODS: A Medline literature search was performed for relevant Medical Subject Heading terms, reviewing publications on strategies for management of acquired EV. We also report a case successfully treated using a combination of photodynamic therapy and oral retinoids. CONCLUSION: Data from the literature show that a standardized approach to this condition is lacking; the combination treatment chosen in our case may be proposed because it led to an excellent clinical outcome and a long-lasting remission.


Subject(s)
Aminolevulinic Acid/analogs & derivatives , Epidermodysplasia Verruciformis/therapy , Photochemotherapy , Photosensitizing Agents/administration & dosage , Retinoids/administration & dosage , Administration, Oral , Aminolevulinic Acid/administration & dosage , Combined Modality Therapy , Diathermy , Epidermodysplasia Verruciformis/immunology , Epidermodysplasia Verruciformis/pathology , Female , Humans , Immunocompromised Host , Middle Aged , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...